Company Overview - Soleno Therapeutics, Inc. (SLNO) currently holds a Momentum Style Score of A, indicating strong potential for momentum investing [3][12] - The company has a Zacks Rank of 2 (Buy), suggesting favorable market performance [4][12] Price Performance - SLNO shares have increased by 6.91% over the past week, while the Zacks Medical - Drugs industry has decreased by 0.38% during the same period [6] - Over the past quarter, SLNO shares have risen by 17.34%, and they have gained 87.5% over the last year, outperforming the S&P 500's increases of 16.43% and 18.63%, respectively [7] Trading Volume - The average 20-day trading volume for SLNO is 1,461,273 shares, which is a useful indicator of market interest and price movement [8] Earnings Outlook - In the past two months, three earnings estimates for SLNO have been revised upwards, while none have been revised downwards, leading to an increase in the consensus estimate from -$3.09 to -$2.33 [10] - For the next fiscal year, two estimates have moved upwards with no downward revisions, indicating positive sentiment regarding future earnings [10]
Soleno Therapeutics, Inc. (SLNO) is a Great Momentum Stock: Should You Buy?